These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15265885)
1. Differences in the kinetics, amplitude, and localization of ERK activation in anergy and priming revealed at the level of individual primary T cells by laser scanning cytometry. Adams CL; Grierson AM; Mowat AM; Harnett MM; Garside P J Immunol; 2004 Aug; 173(3):1579-86. PubMed ID: 15265885 [TBL] [Abstract][Full Text] [Related]
3. A population of in vivo anergized T cells with a lower activation threshold for the induction of CD25 exhibit differential requirements in mobilization of intracellular calcium and mitogen-activated protein kinase activation. Utting O; Teh SJ; Teh HS J Immunol; 2000 Mar; 164(6):2881-9. PubMed ID: 10706673 [TBL] [Abstract][Full Text] [Related]
4. Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy. Crespi D; Massa S; Basso V; Colombetti S; Mueller DL; Mondino A Eur J Immunol; 2002 Sep; 32(9):2500-9. PubMed ID: 12207334 [TBL] [Abstract][Full Text] [Related]
5. Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways. DeSilva DR; Feeser WS; Tancula EJ; Scherle PA J Exp Med; 1996 May; 183(5):2017-23. PubMed ID: 8642312 [TBL] [Abstract][Full Text] [Related]
6. Inverse Rap1 and phospho-ERK expression discriminate the maintenance phase of tolerance and priming of antigen-specific CD4+ T cells in vitro and in vivo. Morton AM; McManus B; Garside P; Mowat AM; Harnett MM J Immunol; 2007 Dec; 179(12):8026-34. PubMed ID: 18056342 [TBL] [Abstract][Full Text] [Related]
7. Adaptive tolerance and clonal anergy are distinct biochemical states. Chiodetti L; Choi S; Barber DL; Schwartz RH J Immunol; 2006 Feb; 176(4):2279-91. PubMed ID: 16455984 [TBL] [Abstract][Full Text] [Related]
8. CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription. Zhang J; Salojin KV; Delovitch TL Int Immunol; 2001 Mar; 13(3):377-84. PubMed ID: 11222507 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38 alpha activation. Ohkusu-Tsukada K; Tominaga N; Udono H; Yui K Mol Cell Biol; 2004 Aug; 24(16):6957-66. PubMed ID: 15282297 [TBL] [Abstract][Full Text] [Related]
10. Targeting the ERK-1/2 signalling pathway results in alloantigen-specific anergy in human T cells. Krieger PM; Säemann MD; Böhmig GA; Mühlbacher F; Zlabinger GJ Transplant Proc; 2002 Aug; 34(5):1403-4. PubMed ID: 12176416 [No Abstract] [Full Text] [Related]
11. Antigen-dependent integration of opposing proximal TCR-signaling cascades determines the functional fate of T lymphocytes. Wolchinsky R; Hod-Marco M; Oved K; Shen-Orr SS; Bendall SC; Nolan GP; Reiter Y J Immunol; 2014 Mar; 192(5):2109-19. PubMed ID: 24489091 [TBL] [Abstract][Full Text] [Related]
12. Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells. Chen D; Heath V; O'Garra A; Johnston J; McMahon M J Immunol; 1999 Dec; 163(11):5796-805. PubMed ID: 10570262 [TBL] [Abstract][Full Text] [Related]
13. Distinct requirements for C-C chemokine and IL-2 production by naive, previously activated, and anergic T cells. Lerner CG; Horton MR; Schwartz RH; Powell JD J Immunol; 2000 Apr; 164(8):3996-4002. PubMed ID: 10754290 [TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance. Kriegel MA; Rathinam C; Flavell RA Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16770-5. PubMed ID: 19805371 [TBL] [Abstract][Full Text] [Related]
16. Live cell fluorescence imaging of T cell MEKK2: redistribution and activation in response to antigen stimulation of the T cell receptor. Schaefer BC; Ware MF; Marrack P; Fanger GR; Kappler JW; Johnson GL; Monks CR Immunity; 1999 Oct; 11(4):411-21. PubMed ID: 10549623 [TBL] [Abstract][Full Text] [Related]
17. The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells. DeSilva DR; Jones EA; Feeser WS; Manos EJ; Scherle PA Cell Immunol; 1997 Sep; 180(2):116-23. PubMed ID: 9341741 [TBL] [Abstract][Full Text] [Related]
18. A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Zheng Y; Collins SL; Lutz MA; Allen AN; Kole TP; Zarek PE; Powell JD J Immunol; 2007 Feb; 178(4):2163-70. PubMed ID: 17277121 [TBL] [Abstract][Full Text] [Related]
19. T cell effector function and anergy avoidance are quantitatively linked to cell division. Wells AD; Walsh MC; Sankaran D; Turka LA J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268 [TBL] [Abstract][Full Text] [Related]
20. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK]. Chang ZL; Lin MQ; Wang MZ; Yao Z Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]